JPMORGAN CHASE & CO - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753U906. A total of 5 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$21,161,652
+172.3%
556,300
+552.2%
0.00%
+100.0%
Q2 2023$7,770,830
-67.7%
85,300
-76.6%
0.00%
-66.7%
Q1 2023$24,056,000
+11621156.0%
364,700
+9017.5%
0.00%
Q4 2022$207
-100.0%
4,000
-94.5%
0.00%
-100.0%
Q3 2022$4,952,000
-41.1%
72,500
-56.2%
0.00%0.0%
Q1 2022$8,409,000
+125.6%
165,500
+46.3%
0.00%
Q3 2021$3,728,000
+98.6%
113,100
+280.8%
0.00%
Q2 2021$1,877,000
+709.1%
29,700
+450.0%
0.00%
Q1 2021$232,000
-96.3%
5,400
-97.4%
0.00%
-100.0%
Q4 2019$6,323,000206,5000.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
PURA VIDA INVESTMENTS, LLC 200,000$9,044,0000.52%
GROUP ONE TRADING, L.P. 49,500$2,238,0000.00%
JANE STREET GROUP, LLC 148,500$6,715,0000.00%
SIMPLEX TRADING, LLC 44,700$2,021,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of APELLIS PHARMACEUTICALS INC shareholders